--- title: "L-Tyrosine: Dosing & Vendor Prices — BodyHackGuide" description: "L-Tyrosine: dosing protocols, mechanism & side effects, 8 PubMed studies. Compare verified vendor prices." lang: en json-ld: | [ { "@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.bodyhackguide.co/" }, { "@type": "ListItem", "position": 2, "name": "Compounds", "item": "https://www.bodyhackguide.co/compare" }, { "@type": "ListItem", "position": 3, "name": "L-Tyrosine" } ] }, { "@context": "https://schema.org", "@type": "MedicalWebPage", "name": "L-Tyrosine", "description": "L-Tyrosine is a non-essential aromatic amino acid and the direct biosynthetic precursor to the catecholamine neurotransmitters dopamine, norepinephrine, and epinephrine. Unlike \"essential\" amino acids that must be obtained from diet, tyrosine can be synthesized in the human body from phenylalanine via the enzyme phenylalanine hydroxylase (PAH) — the same enzyme that is deficient in the genetic disorder phenylketonuria (PKU), which is why PKU patients require dietary tyrosine supplementation as part of their medical management. Dietary sources of tyrosine include cheese (the amino acid was originally isolated from casein, and its name derives from the Greek tyros meaning \"cheese\"), chicken, fish, eggs, nuts, seeds, soy products, and dairy. Typical Western diets provide 1-5 g of tyrosine daily from food sources, which is adequate for general protein synthesis and catecholamine turnover under normal conditions. The cognitive performance use case for supplemental tyrosine rests on a specific pharmacologic logic: during periods of intense acute stress — cold exposure, sleep deprivation, sustained mental workload, combat operations — catecholamine synthesis in the brain can become rate-limited by tyrosine availability at the tyrosine hydroxylase step (the rate-limiting enzyme in catecholamine biosynthesis). Under these conditions, supplemental tyrosine at doses of 100-150 mg/kg (roughly 7-12 g for a 70 kg adult in the original research context, though practical doses are typically lower at 500-2000 mg) can raise brain tyrosine levels, accelerate catecholamine synthesis, and support cognitive performance that would otherwise degrade under stress. The seminal research establishing this cognitive-performance effect came from US Army and academic laboratories in the 1980s-1990s, with Banderet and Lieberman's 1989 work at the US Army Research Institute of Environmental Medicine demonstrating that tyrosine supplementation protected cognitive performance in subjects exposed to cold and altitude stress (PMID 2736402). Subsequent research extended these findings to sleep deprivation, combat operational stress, cognitively demanding military scenarios, and laboratory stress paradigms. A body of 30+ studies now documents tyrosine's cognitive protective effects under stress conditions, with a reasonably consistent finding: tyrosine provides modest but real cognitive performance protection during demanding conditions while producing minimal effects in rested, non-stressed users. The practical implication is that tyrosine is a niche cognitive enhancer rather than a general nootropic — it matters for specific situations (sleep-deprived work, cold exposure, high-stress cognitive challenges) and matters less for routine rested cognitive function. This entry covers tyrosine's mechanism of action as a catecholamine precursor and the pharmacologic logic of precursor loading; the clinical and military research evidence base for cognitive performance under stress including the Banderet-Lieberman and subsequent studies; the distinction between L-tyrosine and N-acetyl-L-tyrosine (NALT) and their relative bioavailability claims; the side effect profile including rare effects on thyroid function, blood pressure, and melanin synthesis; dosing conventions for acute pre-stress loading versus chronic daily supplementation; contraindications including MAO inhibitor use, active melanoma, and hyperthyroidism; and how tyrosine integrates into stacks with other cognitive enhancement and performance compounds including Modafinil, Piracetam, Noopept, Sulbutiamine, L-Theanine, Bromantane, Selank, and Semax. Tyrosine represents a well-understood, evidence-supported, low-risk cognitive performance intervention for specific stress-related applications — one of the few nootropic supplements with multiple rigorous randomized controlled trials supporting its use.", "lastReviewed": "2026-05-04T11:34:56.406+00:00", "url": "https://www.bodyhackguide.co/compound/l-tyrosine", "author": { "@type": "Person", "name": "BioChonch", "url": "https://www.bodyhackguide.co/about", "jobTitle": "Founder & Lead Researcher", "sameAs": [ "https://x.com/bodyhackguide", "https://reddit.com/r/BodyHackGuide", "https://reddit.com/r/BrainHackGuide", "https://reddit.com/r/Biohackingher" ], "worksFor": { "@type": "Organization", "name": "BodyHackGuide", "url": "https://www.bodyhackguide.co" } }, "reviewedBy": { "@type": "Person", "name": "BioChonch", "url": "https://www.bodyhackguide.co/about", "jobTitle": "Founder & Lead Researcher", "sameAs": [ "https://x.com/bodyhackguide", "https://reddit.com/r/BodyHackGuide", "https://reddit.com/r/BrainHackGuide", "https://reddit.com/r/Biohackingher" ], "worksFor": { "@type": "Organization", "name": "BodyHackGuide", "url": "https://www.bodyhackguide.co" } }, "publisher": { "@type": "Organization", "name": "BodyHackGuide", "url": "https://www.bodyhackguide.co" }, "mainContentOfPage": { "@type": "WebPageElement", "cssSelector": "main" }, "about": { "@type": "Drug", "name": "L-Tyrosine", "alternateName": [ "Tyrosine", "L-Tyr", "2-Amino-3-(4-hydroxyphenyl)propanoic acid", "NALT", "N-Acetyl-L-Tyrosine" ], "description": "L-Tyrosine is a non-essential aromatic amino acid and the direct biosynthetic precursor to the catecholamine neurotransmitters dopamine, norepinephrine, and epinephrine. Unlike \"essential\" amino acids that must be obtained from diet, tyrosine can be synthesized in the human body from phenylalanine via the enzyme phenylalanine hydroxylase (PAH) — the same enzyme that is deficient in the genetic disorder phenylketonuria (PKU), which is why PKU patients require dietary tyrosine supplementation as part of their medical management. Dietary sources of tyrosine include cheese (the amino acid was originally isolated from casein, and its name derives from the Greek tyros meaning \"cheese\"), chicken, fish, eggs, nuts, seeds, soy products, and dairy. Typical Western diets provide 1-5 g of tyrosine daily from food sources, which is adequate for general protein synthesis and catecholamine turnover under normal conditions. The cognitive performance use case for supplemental tyrosine rests on a specific pharmacologic logic: during periods of intense acute stress — cold exposure, sleep deprivation, sustained mental workload, combat operations — catecholamine synthesis in the brain can become rate-limited by tyrosine availability at the tyrosine hydroxylase step (the rate-limiting enzyme in catecholamine biosynthesis). Under these conditions, supplemental tyrosine at doses of 100-150 mg/kg (roughly 7-12 g for a 70 kg adult in the original research context, though practical doses are typically lower at 500-2000 mg) can raise brain tyrosine levels, accelerate catecholamine synthesis, and support cognitive performance that would otherwise degrade under stress. The seminal research establishing this cognitive-performance effect came from US Army and academic laboratories in the 1980s-1990s, with Banderet and Lieberman's 1989 work at the US Army Research Institute of Environmental Medicine demonstrating that tyrosine supplementation protected cognitive performance in subjects exposed to cold and altitude stress (PMID 2736402). Subsequent research extended these findings to sleep deprivation, combat operational stress, cognitively demanding military scenarios, and laboratory stress paradigms. A body of 30+ studies now documents tyrosine's cognitive protective effects under stress conditions, with a reasonably consistent finding: tyrosine provides modest but real cognitive performance protection during demanding conditions while producing minimal effects in rested, non-stressed users. The practical implication is that tyrosine is a niche cognitive enhancer rather than a general nootropic — it matters for specific situations (sleep-deprived work, cold exposure, high-stress cognitive challenges) and matters less for routine rested cognitive function. This entry covers tyrosine's mechanism of action as a catecholamine precursor and the pharmacologic logic of precursor loading; the clinical and military research evidence base for cognitive performance under stress including the Banderet-Lieberman and subsequent studies; the distinction between L-tyrosine and N-acetyl-L-tyrosine (NALT) and their relative bioavailability claims; the side effect profile including rare effects on thyroid function, blood pressure, and melanin synthesis; dosing conventions for acute pre-stress loading versus chronic daily supplementation; contraindications including MAO inhibitor use, active melanoma, and hyperthyroidism; and how tyrosine integrates into stacks with other cognitive enhancement and performance compounds including Modafinil, Piracetam, Noopept, Sulbutiamine, L-Theanine, Bromantane, Selank, and Semax. Tyrosine represents a well-understood, evidence-supported, low-risk cognitive performance intervention for specific stress-related applications — one of the few nootropic supplements with multiple rigorous randomized controlled trials supporting its use.", "activeIngredient": "L-Tyrosine", "mechanismOfAction": "L-Tyrosine's mechanism of action as a cognitive performance enhancer reflects its role as the rate-limiting substrate for catecholamine biosynthesis in the brain. The catecholamine synthesis pathway begins with phenylalanine (from dietary protein), which is converted to tyrosine by phenylalanine hydroxylase in the liver. Tyrosine then enters the brain via the large neutral amino acid transporter (LAT1) at the blood-brain barrier, where it competes with other large neutral amino acids (phenylalanine, tryptophan, leucine, isoleucine, valine, methionine) for transport capacity. Within catecholaminergic neurons, tyrosine is converted to L-DOPA by tyrosine hydroxylase (TH), which is the rate-limiting enzyme of the entire catecholamine pathway. L-DOPA is then decarboxylated to dopamine by aromatic L-amino acid decarboxylase (AADC), and dopamine can be further converted to norepinephrine by dopamine beta-hydroxylase (DBH) in noradrenergic neurons or to epinephrine in adrenergic neurons. The rate-limiting nature of tyrosine hydroxylase is critical to understanding when supplemental tyrosine matters. Under baseline conditions with normal catecholamine turnover, TH is not saturated with substrate — brain tyrosine levels are generally adequate for the enzyme to function at its regulated rate. In these baseline conditions, giving additional tyrosine produces minimal effect because the enzyme is already functioning at its optimal regulated rate and is not substrate-limited. However, under conditions of intense catecholamine demand — acute stress, cold exposure, sustained cognitive workload, sleep deprivation — the accelerated firing of catecholaminergic neurons depletes synaptic catecholamines faster than they can be replaced, TH activity is upregulated by phosphorylation and other post-translational modifications, and tyrosine supply can become rate-limiting. Under these specific conditions, supplemental tyrosine raises brain tyrosine levels above the substrate requirement of upregulated TH, accelerates catecholamine synthesis, and prevents the cognitive performance degradation that would otherwise occur from catecholamine depletion. The pharmacology is thus conditional — tyrosine matters for catecholaminergic function when catecholamine demand is elevated, and matters less when demand is normal. This explains the consistent research finding that tyrosine produces cognitive benefits under stress conditions but minimal effects in rested subjects performing non-demanding tasks. Blood-brain barrier transport is the practical bottleneck for tyrosine's cognitive effects. LAT1 at the blood-brain barrier has limited transport capacity and transports large neutral amino acids competitively. Oral tyrosine taken with a protein-containing meal competes with other amino acids from the meal for BBB transport, which can actually reduce the brain tyrosine peak compared to fasted-state administration. The standard practical recommendation is to take tyrosine on an empty stomach or with only carbohydrate-containing meals (which do not compete for LAT1 transport) to maximize brain tyrosine delivery. Peak brain tyrosine concentrations occur 1-2 hours after oral administration of tyrosine in the fasted or carbohydrate-only state. N-Acetyl-L-Tyrosine (NALT) is a commonly marketed alternative to L-tyrosine with claims of improved bioavailability. The theoretical advantage is that the acetyl group improves water solubility and absorption. However, the pharmacokinetic reality is more complex: NALT must be hydrolyzed to L-tyrosine by deacetylase enzymes (primarily in the kidneys) to enter the catecholamine pathway, and this deacetylation is incomplete in humans, producing lower overall tyrosine delivery than equivalent doses of plain L-tyrosine in most comparative studies. The NALT marketing claims of superior bioavailability are generally not supported by direct pharmacokinetic comparisons — plain L-tyrosine is usually preferred for cognitive performance applications. Tyrosine's effects extend beyond catecholamine synthesis to include thyroid hormone synthesis (tyrosine is a substrate for thyroxine/T4 and triiodothyronine/T3 production in the thyroid gland, iodinated at specific tyrosine residues within thyroglobulin), melanin synthesis (tyrosine is the starting material for melanin biosynthesis via tyrosinase in melanocytes), and protein synthesis (tyrosine is incorporated into proteins during translation at UAC/UAU codons). These additional pathways are generally quantitatively less important for cognitive performance applications but matter for safety considerations — tyrosine can theoretically affect thyroid function, skin pigmentation (particularly in individuals with melanoma concerns), and other tyrosine-utilizing pathways. Pharmacokinetically, oral L-tyrosine is well absorbed (>90% bioavailability), reaches peak plasma concentrations 1-2 hours after dosing, has a plasma half-life of approximately 1-2 hours, and is distributed widely throughout body tissues. Catecholamine synthesis effects persist for 3-6 hours after dosing, corresponding to the elevated brain tyrosine level window during which upregulated TH can access additional substrate.", "legalStatus": "Not approved for human use — research chemical", "warning": "For research purposes only. Not for human consumption." } }, { "@context": "https://schema.org", "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "What is L-tyrosine and what does it do?", "acceptedAnswer": { "@type": "Answer", "text": "L-tyrosine is a non-essential aromatic amino acid and the direct biosynthetic precursor to the catecholamine neurotransmitters dopamine, norepinephrine, and epinephrine. Supplemental tyrosine at 500-2000 mg can support catecholamine synthesis during conditions of elevated demand (acute stress, cold exposure, sleep deprivation, sustained cognitive workload), producing modest cognitive performance protection. It is widely used as a dietary supplement for cognitive performance in demanding conditions." } }, { "@type": "Question", "name": "Does L-tyrosine actually work for cognitive enhancement?", "acceptedAnswer": { "@type": "Answer", "text": "Yes, but conditionally. The evidence base from military and academic laboratories (Banderet & Lieberman 1989, PMID 2736402; Thomas et al., Neri et al., Deijen et al.) supports modest cognitive performance benefits under stress conditions — cold, altitude, sleep deprivation, sustained cognitive workload. Effect sizes are modest (Cohen's d 0.2-0.5) but real in adequately powered studies. In rested, unstressed users performing routine cognitive tasks, tyrosine produces minimal detectable effects. Use it for specific demanding situations, not as a general daily cognitive booster." } }, { "@type": "Question", "name": "What is the best L-tyrosine dose?", "acceptedAnswer": { "@type": "Answer", "text": "500-2000 mg taken 30-60 minutes before anticipated cognitive stress, on an empty stomach or with carbohydrate-only snack. Research doses in military studies were 100-150 mg/kg (roughly 7-12 g for a 70 kg adult), but practical doses of 500-2000 mg produce measurable effects with better tolerability. Beginners start at 500-1000 mg; intermediate users use 1000-2000 mg; advanced users may use 1000-3000 mg per dose with 1-3 doses per day during demanding periods." } }, { "@type": "Question", "name": "Is L-tyrosine better on an empty stomach?", "acceptedAnswer": { "@type": "Answer", "text": "Yes. Tyrosine competes with other large neutral amino acids (phenylalanine, tryptophan, leucine, isoleucine, valine) for transport into the brain via the LAT1 transporter at the blood-brain barrier. Taking tyrosine with a protein-rich meal reduces brain tyrosine delivery and dampens the cognitive effect. Take tyrosine on an empty stomach or with carbohydrate-only snacks (fruit, juice, bread). Avoid taking with protein shakes, high-protein meals, or meat/dairy/eggs for optimal cognitive effect." } }, { "@type": "Question", "name": "Is NALT (N-acetyl-L-tyrosine) better than plain L-tyrosine?", "acceptedAnswer": { "@type": "Answer", "text": "No, pharmacokinetic data does not support the bioavailability claims of NALT. While NALT has improved water solubility, it must be deacetylated to L-tyrosine (primarily in kidneys) to enter the catecholamine pathway, and this conversion is incomplete in humans. Studies generally show lower tyrosine delivery from equivalent doses of NALT compared to plain L-tyrosine. Plain L-tyrosine at appropriate doses is the pharmacokinetically preferred form and is usually less expensive. Some users report subjective preference for NALT; these reports do not align with the pharmacokinetic evidence." } }, { "@type": "Question", "name": "Can I take L-tyrosine with coffee, modafinil, or other stimulants?", "acceptedAnswer": { "@type": "Answer", "text": "Yes, combinations are common and generally well-tolerated. Caffeine + L-tyrosine is a well-tested performance stack from military research. Modafinil + L-tyrosine is used to extend modafinil's cognitive effects and reduce fatigue. Piracetam + L-tyrosine + choline is a common nootropic stack. L-Theanine + caffeine + L-tyrosine is a popular morning productivity formula. Monitor for cumulative cardiovascular or anxiety effects with high stimulant combinations. AVOID combining L-tyrosine with MAO inhibitors — this combination can produce dangerous catecholamine elevations." } }, { "@type": "Question", "name": "What are the main L-tyrosine side effects?", "acceptedAnswer": { "@type": "Answer", "text": "Generally minimal. Most common: mild GI effects (nausea, loose stools) usually at higher doses or on empty stomach; mild headache; nervousness or jitteriness in sensitive users; sleep disturbance with late-day dosing. Uncommon: modest BP elevation; thyroid function effects with chronic high-dose use. Serious: MAO inhibitor interaction (dangerous — absolute avoidance); theoretical concern for melanoma progression with high-dose chronic use; hyperthyroidism worsening. At typical supplement doses (500-2000 mg) in healthy users, tyrosine is very well tolerated." } }, { "@type": "Question", "name": "Should I take L-tyrosine every day or only when needed?", "acceptedAnswer": { "@type": "Answer", "text": "For most users, on-demand use (taking tyrosine specifically before anticipated stress or demanding cognitive work) is preferred over chronic daily supplementation. Chronic daily use produces modest adaptation that may reduce acute effect magnitude. On-demand use preserves the pharmacologic effect. Users with continuous cognitive demands (sustained shift work, ongoing high-stress jobs) may adopt daily supplementation with periodic cycling. The principle: tyrosine works best when used with intention for specific purposes rather than as a generic daily supplement." } }, { "@type": "Question", "name": "Will L-tyrosine help with depression or ADHD?", "acceptedAnswer": { "@type": "Answer", "text": "Probably not as a primary treatment. L-tyrosine has been studied for depression and ADHD with generally modest and inconsistent results. It is not an established treatment for either condition and does not compare favorably to evidence-based treatments (SSRIs/SNRIs for depression; stimulants or atomoxetine for ADHD). Some users incorporate tyrosine as adjunctive support for dopaminergic or noradrenergic symptoms not addressed by other treatments, but this is self-directed rather than evidence-based. Patients with diagnosed depression or ADHD should work with their prescribing physician rather than self-treating with tyrosine." } }, { "@type": "Question", "name": "Is L-tyrosine safe for long-term use?", "acceptedAnswer": { "@type": "Answer", "text": "Yes, within typical supplement dose ranges in healthy users. L-tyrosine is a normal dietary amino acid consumed at gram levels daily from food without safety concerns. Supplement doses of 500-2000 mg daily add modestly to dietary intake and are well-tolerated in most users. Long-term chronic high-dose use (>3 g daily for months to years) has not been extensively studied but theoretical concerns exist about thyroid function changes and (weakly) about melanoma risk with very high chronic exposure. Most responsible users adopt on-demand use or moderate daily doses with periodic cycling. Users with specific medical conditions (thyroid disease, melanoma, cardiovascular disease, psychiatric disorders) should discuss long-term use with their physician." } } ] }, { "@context": "https://schema.org", "@type": "Organization", "@id": "https://www.bodyhackguide.co#organization", "name": "BodyHackGuide", "alternateName": "BHG", "url": "https://www.bodyhackguide.co", "logo": { "@type": "ImageObject", "url": "https://www.bodyhackguide.co/logo.png", "width": 512, "height": 512 }, "description": "Evidence-based research reference for peptides and nootropics. 124+ compound profiles, interactive dosing calculators, real-time vendor pricing, and trust-scored vendor reviews scored on a public, reproducible methodology applied to every vendor. BodyHackGuide and BHG Labs share common ownership, and we earn a commission on purchases through our links.", "foundingDate": "2024", "founder": { "@id": "https://www.bodyhackguide.co/about#person" }, "sameAs": [ "https://x.com/bodyhackguide", "https://reddit.com/r/BodyHackGuide", "https://reddit.com/r/BrainHackGuide", "https://reddit.com/r/Biohackingher", "https://discord.gg/Mhq5UdRYBA" ], "knowsAbout": [ "Peptide research", "Nootropic research", "Biohacking", "Compound dosing", "Vendor transparency" ], "publishingPrinciples": "https://www.bodyhackguide.co/editorial-standards", "ethicsPolicy": "https://www.bodyhackguide.co/editorial-standards", "diversityPolicy": "https://www.bodyhackguide.co/editorial-standards" }, { "@context": "https://schema.org", "@type": "MedicalWebPage", "name": "L-Tyrosine", "description": "L-Tyrosine is a non-essential aromatic amino acid and the direct biosynthetic precursor to the catecholamine neurotransmitters dopamine, norepinephrine, and epinephrine. Unlike \"essential\" amino acids that must be obtained from diet, tyrosine can be synthesized in the human body from phenylalanine via the enzyme phenylalanine hydroxylase (PAH) — the same enzyme that is deficient in the genetic disorder phenylketonuria (PKU), which is why PKU patients require dietary tyrosine supplementation as part of their medical management. Dietary sources of tyrosine include cheese (the amino acid was originally isolated from casein, and its name derives from the Greek tyros meaning \"cheese\"), chicken, fish, eggs, nuts, seeds, soy products, and dairy. Typical Western diets provide 1-5 g of tyrosine daily from food sources, which is adequate for general protein synthesis and catecholamine turnover under normal conditions. The cognitive performance use case for supplemental tyrosine rests on a specific pharmacologic logic: during periods of intense acute stress — cold exposure, sleep deprivation, sustained mental workload, combat operations — catecholamine synthesis in the brain can become rate-limited by tyrosine availability at the tyrosine hydroxylase step (the rate-limiting enzyme in catecholamine biosynthesis). Under these conditions, supplemental tyrosine at doses of 100-150 mg/kg (roughly 7-12 g for a 70 kg adult in the original research context, though practical doses are typically lower at 500-2000 mg) can raise brain tyrosine levels, accelerate catecholamine synthesis, and support cognitive performance that would otherwise degrade under stress. The seminal research establishing this cognitive-performance effect came from US Army and academic laboratories in the 1980s-1990s, with Banderet and Lieberman's 1989 work at the US Army Research Institute of Environmental Medicine demonstrating that tyrosine supplementation protected cognitive performance in subjects exposed to cold and altitude stress (PMID 2736402). Subsequent research extended these findings to sleep deprivation, combat operational stress, cognitively demanding military scenarios, and laboratory stress paradigms. A body of 30+ studies now documents tyrosine's cognitive protective effects under stress conditions, with a reasonably consistent finding: tyrosine provides modest but real cognitive performance protection during demanding conditions while producing minimal effects in rested, non-stressed users. The practical implication is that tyrosine is a niche cognitive enhancer rather than a general nootropic — it matters for specific situations (sleep-deprived work, cold exposure, high-stress cognitive challenges) and matters less for routine rested cognitive function. This entry covers tyrosine's mechanism of action as a catecholamine precursor and the pharmacologic logic of precursor loading; the clinical and military research evidence base for cognitive performance under stress including the Banderet-Lieberman and subsequent studies; the distinction between L-tyrosine and N-acetyl-L-tyrosine (NALT) and their relative bioavailability claims; the side effect profile including rare effects on thyroid function, blood pressure, and melanin synthesis; dosing conventions for acute pre-stress loading versus chronic daily supplementation; contraindications including MAO inhibitor use, active melanoma, and hyperthyroidism; and how tyrosine integrates into stacks with other cognitive enhancement and performance compounds including Modafinil, Piracetam, Noopept, Sulbutiamine, L-Theanine, Bromantane, Selank, and Semax. Tyrosine represents a well-understood, evidence-supported, low-risk cognitive performance intervention for specific stress-related applications — one of the few nootropic supplements with multiple rigorous randomized controlled trials supporting its use.", "lastReviewed": "2026-05-04T11:34:56.406+00:00", "url": "https://www.bodyhackguide.co/compound/l-tyrosine", "author": { "@type": "Person", "name": "BioChonch", "url": "https://www.bodyhackguide.co/about", "jobTitle": "Founder & Lead Researcher", "sameAs": [ "https://x.com/bodyhackguide", "https://reddit.com/r/BodyHackGuide", "https://reddit.com/r/BrainHackGuide", "https://reddit.com/r/Biohackingher" ], "worksFor": { "@type": "Organization", "name": "BodyHackGuide", "url": "https://www.bodyhackguide.co" } }, "reviewedBy": { "@type": "Person", "name": "BioChonch", "url": "https://www.bodyhackguide.co/about", "jobTitle": "Founder & Lead Researcher", "sameAs": [ "https://x.com/bodyhackguide", "https://reddit.com/r/BodyHackGuide", "https://reddit.com/r/BrainHackGuide", "https://reddit.com/r/Biohackingher" ], "worksFor": { "@type": "Organization", "name": "BodyHackGuide", "url": "https://www.bodyhackguide.co" } }, "publisher": { "@type": "Organization", "name": "BodyHackGuide", "url": "https://www.bodyhackguide.co" }, "mainContentOfPage": { "@type": "WebPageElement", "cssSelector": "main" }, "about": { "@type": "Drug", "name": "L-Tyrosine", "alternateName": [ "Tyrosine", "L-Tyr", "2-Amino-3-(4-hydroxyphenyl)propanoic acid", "NALT", "N-Acetyl-L-Tyrosine" ], "description": "L-Tyrosine is a non-essential aromatic amino acid and the direct biosynthetic precursor to the catecholamine neurotransmitters dopamine, norepinephrine, and epinephrine. Unlike \"essential\" amino acids that must be obtained from diet, tyrosine can be synthesized in the human body from phenylalanine via the enzyme phenylalanine hydroxylase (PAH) — the same enzyme that is deficient in the genetic disorder phenylketonuria (PKU), which is why PKU patients require dietary tyrosine supplementation as part of their medical management. Dietary sources of tyrosine include cheese (the amino acid was originally isolated from casein, and its name derives from the Greek tyros meaning \"cheese\"), chicken, fish, eggs, nuts, seeds, soy products, and dairy. Typical Western diets provide 1-5 g of tyrosine daily from food sources, which is adequate for general protein synthesis and catecholamine turnover under normal conditions. The cognitive performance use case for supplemental tyrosine rests on a specific pharmacologic logic: during periods of intense acute stress — cold exposure, sleep deprivation, sustained mental workload, combat operations — catecholamine synthesis in the brain can become rate-limited by tyrosine availability at the tyrosine hydroxylase step (the rate-limiting enzyme in catecholamine biosynthesis). Under these conditions, supplemental tyrosine at doses of 100-150 mg/kg (roughly 7-12 g for a 70 kg adult in the original research context, though practical doses are typically lower at 500-2000 mg) can raise brain tyrosine levels, accelerate catecholamine synthesis, and support cognitive performance that would otherwise degrade under stress. The seminal research establishing this cognitive-performance effect came from US Army and academic laboratories in the 1980s-1990s, with Banderet and Lieberman's 1989 work at the US Army Research Institute of Environmental Medicine demonstrating that tyrosine supplementation protected cognitive performance in subjects exposed to cold and altitude stress (PMID 2736402). Subsequent research extended these findings to sleep deprivation, combat operational stress, cognitively demanding military scenarios, and laboratory stress paradigms. A body of 30+ studies now documents tyrosine's cognitive protective effects under stress conditions, with a reasonably consistent finding: tyrosine provides modest but real cognitive performance protection during demanding conditions while producing minimal effects in rested, non-stressed users. The practical implication is that tyrosine is a niche cognitive enhancer rather than a general nootropic — it matters for specific situations (sleep-deprived work, cold exposure, high-stress cognitive challenges) and matters less for routine rested cognitive function. This entry covers tyrosine's mechanism of action as a catecholamine precursor and the pharmacologic logic of precursor loading; the clinical and military research evidence base for cognitive performance under stress including the Banderet-Lieberman and subsequent studies; the distinction between L-tyrosine and N-acetyl-L-tyrosine (NALT) and their relative bioavailability claims; the side effect profile including rare effects on thyroid function, blood pressure, and melanin synthesis; dosing conventions for acute pre-stress loading versus chronic daily supplementation; contraindications including MAO inhibitor use, active melanoma, and hyperthyroidism; and how tyrosine integrates into stacks with other cognitive enhancement and performance compounds including Modafinil, Piracetam, Noopept, Sulbutiamine, L-Theanine, Bromantane, Selank, and Semax. Tyrosine represents a well-understood, evidence-supported, low-risk cognitive performance intervention for specific stress-related applications — one of the few nootropic supplements with multiple rigorous randomized controlled trials supporting its use.", "activeIngredient": "L-Tyrosine", "mechanismOfAction": "L-Tyrosine's mechanism of action as a cognitive performance enhancer reflects its role as the rate-limiting substrate for catecholamine biosynthesis in the brain. The catecholamine synthesis pathway begins with phenylalanine (from dietary protein), which is converted to tyrosine by phenylalanine hydroxylase in the liver. Tyrosine then enters the brain via the large neutral amino acid transporter (LAT1) at the blood-brain barrier, where it competes with other large neutral amino acids (phenylalanine, tryptophan, leucine, isoleucine, valine, methionine) for transport capacity. Within catecholaminergic neurons, tyrosine is converted to L-DOPA by tyrosine hydroxylase (TH), which is the rate-limiting enzyme of the entire catecholamine pathway. L-DOPA is then decarboxylated to dopamine by aromatic L-amino acid decarboxylase (AADC), and dopamine can be further converted to norepinephrine by dopamine beta-hydroxylase (DBH) in noradrenergic neurons or to epinephrine in adrenergic neurons. The rate-limiting nature of tyrosine hydroxylase is critical to understanding when supplemental tyrosine matters. Under baseline conditions with normal catecholamine turnover, TH is not saturated with substrate — brain tyrosine levels are generally adequate for the enzyme to function at its regulated rate. In these baseline conditions, giving additional tyrosine produces minimal effect because the enzyme is already functioning at its optimal regulated rate and is not substrate-limited. However, under conditions of intense catecholamine demand — acute stress, cold exposure, sustained cognitive workload, sleep deprivation — the accelerated firing of catecholaminergic neurons depletes synaptic catecholamines faster than they can be replaced, TH activity is upregulated by phosphorylation and other post-translational modifications, and tyrosine supply can become rate-limiting. Under these specific conditions, supplemental tyrosine raises brain tyrosine levels above the substrate requirement of upregulated TH, accelerates catecholamine synthesis, and prevents the cognitive performance degradation that would otherwise occur from catecholamine depletion. The pharmacology is thus conditional — tyrosine matters for catecholaminergic function when catecholamine demand is elevated, and matters less when demand is normal. This explains the consistent research finding that tyrosine produces cognitive benefits under stress conditions but minimal effects in rested subjects performing non-demanding tasks. Blood-brain barrier transport is the practical bottleneck for tyrosine's cognitive effects. LAT1 at the blood-brain barrier has limited transport capacity and transports large neutral amino acids competitively. Oral tyrosine taken with a protein-containing meal competes with other amino acids from the meal for BBB transport, which can actually reduce the brain tyrosine peak compared to fasted-state administration. The standard practical recommendation is to take tyrosine on an empty stomach or with only carbohydrate-containing meals (which do not compete for LAT1 transport) to maximize brain tyrosine delivery. Peak brain tyrosine concentrations occur 1-2 hours after oral administration of tyrosine in the fasted or carbohydrate-only state. N-Acetyl-L-Tyrosine (NALT) is a commonly marketed alternative to L-tyrosine with claims of improved bioavailability. The theoretical advantage is that the acetyl group improves water solubility and absorption. However, the pharmacokinetic reality is more complex: NALT must be hydrolyzed to L-tyrosine by deacetylase enzymes (primarily in the kidneys) to enter the catecholamine pathway, and this deacetylation is incomplete in humans, producing lower overall tyrosine delivery than equivalent doses of plain L-tyrosine in most comparative studies. The NALT marketing claims of superior bioavailability are generally not supported by direct pharmacokinetic comparisons — plain L-tyrosine is usually preferred for cognitive performance applications. Tyrosine's effects extend beyond catecholamine synthesis to include thyroid hormone synthesis (tyrosine is a substrate for thyroxine/T4 and triiodothyronine/T3 production in the thyroid gland, iodinated at specific tyrosine residues within thyroglobulin), melanin synthesis (tyrosine is the starting material for melanin biosynthesis via tyrosinase in melanocytes), and protein synthesis (tyrosine is incorporated into proteins during translation at UAC/UAU codons). These additional pathways are generally quantitatively less important for cognitive performance applications but matter for safety considerations — tyrosine can theoretically affect thyroid function, skin pigmentation (particularly in individuals with melanoma concerns), and other tyrosine-utilizing pathways. Pharmacokinetically, oral L-tyrosine is well absorbed (>90% bioavailability), reaches peak plasma concentrations 1-2 hours after dosing, has a plasma half-life of approximately 1-2 hours, and is distributed widely throughout body tissues. Catecholamine synthesis effects persist for 3-6 hours after dosing, corresponding to the elevated brain tyrosine level window during which upregulated TH can access additional substrate.", "legalStatus": "Not approved for human use — research chemical", "warning": "For research purposes only. Not for human consumption." } }, { "@context": "https://schema.org", "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "What is L-tyrosine and what does it do?", "acceptedAnswer": { "@type": "Answer", "text": "L-tyrosine is a non-essential aromatic amino acid and the direct biosynthetic precursor to the catecholamine neurotransmitters dopamine, norepinephrine, and epinephrine. Supplemental tyrosine at 500-2000 mg can support catecholamine synthesis during conditions of elevated demand (acute stress, cold exposure, sleep deprivation, sustained cognitive workload), producing modest cognitive performance protection. It is widely used as a dietary supplement for cognitive performance in demanding conditions." } }, { "@type": "Question", "name": "Does L-tyrosine actually work for cognitive enhancement?", "acceptedAnswer": { "@type": "Answer", "text": "Yes, but conditionally. The evidence base from military and academic laboratories (Banderet & Lieberman 1989, PMID 2736402; Thomas et al., Neri et al., Deijen et al.) supports modest cognitive performance benefits under stress conditions — cold, altitude, sleep deprivation, sustained cognitive workload. Effect sizes are modest (Cohen's d 0.2-0.5) but real in adequately powered studies. In rested, unstressed users performing routine cognitive tasks, tyrosine produces minimal detectable effects. Use it for specific demanding situations, not as a general daily cognitive booster." } }, { "@type": "Question", "name": "What is the best L-tyrosine dose?", "acceptedAnswer": { "@type": "Answer", "text": "500-2000 mg taken 30-60 minutes before anticipated cognitive stress, on an empty stomach or with carbohydrate-only snack. Research doses in military studies were 100-150 mg/kg (roughly 7-12 g for a 70 kg adult), but practical doses of 500-2000 mg produce measurable effects with better tolerability. Beginners start at 500-1000 mg; intermediate users use 1000-2000 mg; advanced users may use 1000-3000 mg per dose with 1-3 doses per day during demanding periods." } }, { "@type": "Question", "name": "Is L-tyrosine better on an empty stomach?", "acceptedAnswer": { "@type": "Answer", "text": "Yes. Tyrosine competes with other large neutral amino acids (phenylalanine, tryptophan, leucine, isoleucine, valine) for transport into the brain via the LAT1 transporter at the blood-brain barrier. Taking tyrosine with a protein-rich meal reduces brain tyrosine delivery and dampens the cognitive effect. Take tyrosine on an empty stomach or with carbohydrate-only snacks (fruit, juice, bread). Avoid taking with protein shakes, high-protein meals, or meat/dairy/eggs for optimal cognitive effect." } }, { "@type": "Question", "name": "Is NALT (N-acetyl-L-tyrosine) better than plain L-tyrosine?", "acceptedAnswer": { "@type": "Answer", "text": "No, pharmacokinetic data does not support the bioavailability claims of NALT. While NALT has improved water solubility, it must be deacetylated to L-tyrosine (primarily in kidneys) to enter the catecholamine pathway, and this conversion is incomplete in humans. Studies generally show lower tyrosine delivery from equivalent doses of NALT compared to plain L-tyrosine. Plain L-tyrosine at appropriate doses is the pharmacokinetically preferred form and is usually less expensive. Some users report subjective preference for NALT; these reports do not align with the pharmacokinetic evidence." } }, { "@type": "Question", "name": "Can I take L-tyrosine with coffee, modafinil, or other stimulants?", "acceptedAnswer": { "@type": "Answer", "text": "Yes, combinations are common and generally well-tolerated. Caffeine + L-tyrosine is a well-tested performance stack from military research. Modafinil + L-tyrosine is used to extend modafinil's cognitive effects and reduce fatigue. Piracetam + L-tyrosine + choline is a common nootropic stack. L-Theanine + caffeine + L-tyrosine is a popular morning productivity formula. Monitor for cumulative cardiovascular or anxiety effects with high stimulant combinations. AVOID combining L-tyrosine with MAO inhibitors — this combination can produce dangerous catecholamine elevations." } }, { "@type": "Question", "name": "What are the main L-tyrosine side effects?", "acceptedAnswer": { "@type": "Answer", "text": "Generally minimal. Most common: mild GI effects (nausea, loose stools) usually at higher doses or on empty stomach; mild headache; nervousness or jitteriness in sensitive users; sleep disturbance with late-day dosing. Uncommon: modest BP elevation; thyroid function effects with chronic high-dose use. Serious: MAO inhibitor interaction (dangerous — absolute avoidance); theoretical concern for melanoma progression with high-dose chronic use; hyperthyroidism worsening. At typical supplement doses (500-2000 mg) in healthy users, tyrosine is very well tolerated." } }, { "@type": "Question", "name": "Should I take L-tyrosine every day or only when needed?", "acceptedAnswer": { "@type": "Answer", "text": "For most users, on-demand use (taking tyrosine specifically before anticipated stress or demanding cognitive work) is preferred over chronic daily supplementation. Chronic daily use produces modest adaptation that may reduce acute effect magnitude. On-demand use preserves the pharmacologic effect. Users with continuous cognitive demands (sustained shift work, ongoing high-stress jobs) may adopt daily supplementation with periodic cycling. The principle: tyrosine works best when used with intention for specific purposes rather than as a generic daily supplement." } }, { "@type": "Question", "name": "Will L-tyrosine help with depression or ADHD?", "acceptedAnswer": { "@type": "Answer", "text": "Probably not as a primary treatment. L-tyrosine has been studied for depression and ADHD with generally modest and inconsistent results. It is not an established treatment for either condition and does not compare favorably to evidence-based treatments (SSRIs/SNRIs for depression; stimulants or atomoxetine for ADHD). Some users incorporate tyrosine as adjunctive support for dopaminergic or noradrenergic symptoms not addressed by other treatments, but this is self-directed rather than evidence-based. Patients with diagnosed depression or ADHD should work with their prescribing physician rather than self-treating with tyrosine." } }, { "@type": "Question", "name": "Is L-tyrosine safe for long-term use?", "acceptedAnswer": { "@type": "Answer", "text": "Yes, within typical supplement dose ranges in healthy users. L-tyrosine is a normal dietary amino acid consumed at gram levels daily from food without safety concerns. Supplement doses of 500-2000 mg daily add modestly to dietary intake and are well-tolerated in most users. Long-term chronic high-dose use (>3 g daily for months to years) has not been extensively studied but theoretical concerns exist about thyroid function changes and (weakly) about melanoma risk with very high chronic exposure. Most responsible users adopt on-demand use or moderate daily doses with periodic cycling. Users with specific medical conditions (thyroid disease, melanoma, cardiovascular disease, psychiatric disorders) should discuss long-term use with their physician." } } ] }, { "@context": "https://schema.org", "@type": "Organization", "@id": "https://www.bodyhackguide.co#organization", "name": "BodyHackGuide", "alternateName": "BHG", "url": "https://www.bodyhackguide.co", "logo": { "@type": "ImageObject", "url": "https://www.bodyhackguide.co/logo.png", "width": 512, "height": 512 }, "description": "Evidence-based research reference for peptides and nootropics. 124+ compound profiles, interactive dosing calculators, real-time vendor pricing, and trust-scored vendor reviews scored on a public, reproducible methodology applied to every vendor. BodyHackGuide and BHG Labs share common ownership, and we earn a commission on purchases through our links.", "foundingDate": "2024", "founder": { "@id": "https://www.bodyhackguide.co/about#person" }, "sameAs": [ "https://x.com/bodyhackguide", "https://reddit.com/r/BodyHackGuide", "https://reddit.com/r/BrainHackGuide", "https://reddit.com/r/Biohackingher", "https://discord.gg/Mhq5UdRYBA" ], "knowsAbout": [ "Peptide research", "Nootropic research", "Biohacking", "Compound dosing", "Vendor transparency" ], "publishingPrinciples": "https://www.bodyhackguide.co/editorial-standards", "ethicsPolicy": "https://www.bodyhackguide.co/editorial-standards", "diversityPolicy": "https://www.bodyhackguide.co/editorial-standards" } ] --- [Skip to content](#main-content) ## Research Use Only This site is an **educational resource** for research compounds. We do **not endorse** human consumption of any compound. BodyHackGuide and **BHG Labs share common ownership**; we rank every vendor on the same public methodology, and we earn a commission on purchases through our links. By entering, you confirm you are **21 years of age or older** and agree to our [Terms](/terms) & [Privacy Policy](/privacy). I'm 21+ — Enter SiteLeave site [![BodyHackGuide](/assets/bodyhackguide-logo-DOzZNUyh.webp)BodyHackGuide ](/) [Compare](/compare)[Wiki](/wiki)[Vendors](/vendors)[Deals](/deals)[Stacks](/stack-builder)[Nootropics](/nootropics)[Tools](/tools) Learn Community Search ⌘K [Sign In](/auth?returnTo=%2Fcompound%2Fl-tyrosine) 100K+ researchers trust BodyHackGuide — Join [r/BodyHackGuide](https://reddit.com/r/bodyhackguide) 1. [Home](/) 2. [Compounds](/compare) 3. L-Tyrosine [Where to buy L-Tyrosine](/buy/l-tyrosine) [L-Tyrosine coupon codes](/coupons/l-tyrosine) [L-Tyrosine protocol](/protocol/l-tyrosine) [Alternatives to L-Tyrosine](/alternatives-to/l-tyrosine) [L-Tyrosine side effects](/side-effects/l-tyrosine) 1. [Home](/) 3. [Compounds](/compare) 5. L-Tyrosine # L-Tyrosine Nootropics Preclinical Download PDF Also known as: Tyrosine, L-Tyr, 2-Amino-3-(4-hydroxyphenyl)propanoic acid, NALT, N-Acetyl-L-Tyrosine L-Tyrosine is a non-essential aromatic amino acid and the direct biosynthetic precursor to the catecholamine neurotransmitters dopamine, norepinephrine, and epinephrine. Unlike "essential" amino acids that must be obtained from diet, tyrosine can be synthesized in the human body from phenylalanine via the enzyme phenylalanine hydroxylase (PAH) — the same enzyme that is deficient in the genetic disorder phenylketonuria (PKU), which is why PKU patients require dietary tyrosine supplementation as part of their medical management. [8 PubMed Studies](https://pubmed.ncbi.nlm.nih.gov/?term=L-tyrosine%20cognitive%20performance%20stress%20dopamine%20precursor) Last reviewed: May 4, 2026 [ 8 PubMed Studies ](https://pubmed.ncbi.nlm.nih.gov/?term=L-tyrosine%20cognitive%20performance%20stress%20dopamine%20precursor)[ Nootropics Category ](/wiki#cat-nootropics) Preclinical Research Stage OverviewChemical InfoDosing & ProtocolsInteractionsResearchCompare PricesRelated ## Overview ### At A Glance Mechanism L-Tyrosine's mechanism of action as a cognitive performance enhancer reflects its role as the rate-limiting substrate for catecholamine biosynthesis in the brain. The catecholamine synthesis pathway begins with phenylalanine (from dietary protein), which is converted to tyrosine … ### Overview L-Tyrosine is a non-essential aromatic amino acid and the direct biosynthetic precursor to the catecholamine neurotransmitters dopamine, norepinephrine, and epinephrine. Unlike "essential" amino acids that must be obtained from diet, tyrosine can be synthesized in the human body from phenylalanine via the enzyme phenylalanine hydroxylase (PAH) — the same enzyme that is deficient in the genetic disorder phenylketonuria (PKU), which is why PKU patients require dietary tyrosine supplementation as part of their medical management. Dietary sources of tyrosine include cheese (the amino acid was originally isolated from casein, and its name derives from the Greek _tyros_ meaning "cheese"), chicken, fish, eggs, nuts, seeds, soy products, and dairy. Typical Western diets provide 1-5 g of tyrosine daily from food sources, which is adequate for general protein synthesis and catecholamine turnover under normal conditions. The cognitive performance use case for supplemental tyrosine rests on a specific pharmacologic logic: during periods of intense acute stress — cold exposure, sleep deprivation, sustained mental workload, combat operations — catecholamine synthesis in the brain can become rate-limited by tyrosine availability at the tyrosine hydroxylase step (the rate-limiting enzyme in catecholamine biosynthesis). Under these conditions, supplemental tyrosine at doses of 100-150 mg/kg (roughly 7-12 g for a 70 kg adult in the original research context, though practical doses are typically lower at 500-2000 mg) can raise brain tyrosine levels, accelerate catecholamine synthesis, and support cognitive performance that would otherwise degrade under stress. The seminal research establishing this cognitive-performance effect came from US Army and academic laboratories in the 1980s-1990s, with Banderet and Lieberman's 1989 work at the US Army Research Institute of Environmental Medicine demonstrating that tyrosine supplementation protected cognitive performance in subjects exposed to cold and altitude stress (PMID 2736402). Subsequent research extended these findings to sleep deprivation, combat operational stress, cognitively demanding military scenarios, and laboratory stress paradigms. A body of 30+ studies now documents tyrosine's cognitive protective effects under stress conditions, with a reasonably consistent finding: tyrosine provides modest but real cognitive performance protection during demanding conditions while producing minimal effects in rested, non-stressed users. The practical implication is that tyrosine is a niche cognitive enhancer rather than a general nootropic — it matters for specific situations (sleep-deprived work, cold exposure, high-stress cognitive challenges) and matters less for routine rested cognitive function. This entry covers tyrosine's mechanism of action as a catecholamine precursor and the pharmacologic logic of precursor loading; the clinical and military research evidence base for cognitive performance under stress including the Banderet-Lieberman and subsequent studies; the distinction between L-tyrosine and N-acetyl-L-tyrosine (NALT) and their relative bioavailability claims; the side effect profile including rare effects on thyroid function, blood pressure, and melanin synthesis; dosing conventions for acute pre-stress loading versus chronic daily supplementation; contraindications including MAO inhibitor use, active melanoma, and hyperthyroidism; and how tyrosine integrates into stacks with other cognitive enhancement and performance compounds including [Modafinil](/compound/modafinil), [Piracetam](/compound/piracetam), [Noopept](/compound/noopept), [Sulbutiamine](/compound/sulbutiamine), [L-Theanine](/compound/l-theanine), [Bromantane](/compound/bromantane), [Selank](/compound/selank), and [Semax](/compound/semax). Tyrosine represents a well-understood, evidence-supported, low-risk cognitive performance intervention for specific stress-related applications — one of the few nootropic supplements with multiple rigorous randomized controlled trials supporting its use. ## Chemical Information IUPAC Name Not yet available CAS Number Not yet available Molecular Formula Not yet available Molecular Mass Not yet available Chemical data is being compiled for this compound. ## Dosing & Protocols ### Unlock Dosing Protocols Free account gets you: - View beginner, intermediate & advanced protocols - See weight-based dosing calculations - Access cycle length & frequency data [Create free account](/auth)[Sign in](/auth) 2,800+ researchers already in ## Research ### Unlock Research Data Free account gets you: - Browse PubMed study summaries - See clinical trial phases & results - Access mechanism of action details [Create free account](/auth)[Sign in](/auth) 2,800+ researchers already in ## Interactions ### Contraindications L-Tyrosine has a favorable contraindication profile reflecting its status as a normal dietary amino acid. Absolute contraindications are few: concurrent MAO inhibitor therapy (phenelzine, tranylcypromine, isocarboxazid, moclobemide, and similar) or recent MAO inhibitor discontinuation (within 2 weeks) — this combination can produce dangerous catecholamine elevations with risk of hypertensive crisis, cardiac arrhythmias, or sympathomimetic toxicity; known hypersensitivity to L-tyrosine or supplement components. Significant contraindications: active melanoma or recent melanoma treatment — the theoretical concern about tyrosine-supporting melanin synthesis via tyrosinase, while not extensively documented in clinical studies, is sufficient basis to avoid high-dose chronic tyrosine in patients with active melanoma. Patients with strong personal or family history of melanoma should consult their oncologist or dermatologist before starting L-tyrosine supplementation. Hyperthyroidism and Graves' disease: tyrosine is a substrate for thyroid hormone synthesis, and chronic supplementation could theoretically worsen hyperthyroid states. Patients with hyperthyroidism, treated Graves' disease, or thyroid nodules under evaluation should avoid or use L-tyrosine only with endocrinology oversight. Relative contraindications and precautions: hypertension — tyrosine's catecholaminergic effects can modestly increase blood pressure; patients with uncontrolled hypertension should avoid L-tyrosine or use low doses with close BP monitoring; patients with controlled hypertension can usually use L-tyrosine but should monitor BP trends. Cardiovascular disease (recent MI, unstable angina, arrhythmias): similar considerations; use only with cardiology oversight if at all. Parkinson's disease on L-DOPA therapy: tyrosine and L-DOPA compete for BBB LAT1 transport; dosing at different times than L-DOPA (3-4 hours separation) may minimize interference but the combination is generally not ideal. Phenylketonuria (PKU): patients with PKU cannot convert phenylalanine to tyrosine effectively, and supplemental tyrosine is actually part of their medical management rather than a concern — this is an indication rather than a contraindication. Pregnancy: tyrosine is a normal dietary component and supplemental doses within the typical range (500-2000 mg daily) are not expected to cause pregnancy complications. Higher doses have not been extensively studied in pregnancy. Pregnant women should consult their physician before starting L-tyrosine supplementation. Breastfeeding: similar to pregnancy — normal dietary ranges are not concerning; higher doses should be discussed with the physician. Pediatric use: safe in children with PKU at medically directed doses. Cognitive performance supplementation in healthy children should be avoided without specific medical guidance. Psychiatric disorders: bipolar disorder may theoretically be worsened by catecholaminergic activation, though clinically significant effects at typical supplement doses are uncommon. Patients with bipolar disorder should discuss L-tyrosine with their psychiatrist before use. Schizophrenia: dopaminergic activation is generally contraindicated in active psychosis; patients with schizophrenia or schizoaffective disorder should not use L-tyrosine outside of psychiatric supervision. Anxiety disorders: may be worsened by tyrosine's activating effects; users with significant anxiety should test with caution or avoid. Renal impairment: tyrosine is not primarily renally cleared and does not accumulate significantly in renal impairment. Dose adjustment is not typically required but common sense suggests avoiding chronic high doses in advanced kidney disease. Hepatic impairment: tyrosine metabolism is primarily enzymatic at sites of catecholamine synthesis rather than hepatic; significant hepatic impairment does not require dose adjustment. Drug interactions of clinical concern: MAO inhibitors (absolute avoidance — the most important drug interaction); amphetamines and methylphenidate (theoretical additive catecholamine effects; coordinate with prescriber); SSRIs and SNRIs (generally compatible; some stack designers use tyrosine as adjunctive support); L-DOPA (timing separation to avoid LAT1 competition); thyroid hormone replacement (possible modest effects on thyroid requirements over time, monitor TSH); cardiovascular medications (additive blood pressure effects possible in some combinations); other catecholaminergic compounds (additive effects). Compounds that are generally compatible: caffeine, L-theanine, modafinil (with monitoring), piracetam, noopept, sulbutiamine, omega-3 fatty acids, B-complex vitamins, magnesium, most supplements and prescription medications not in the above categories. Absence of clinical oversight is the general consideration. For healthy adults using L-tyrosine within the typical supplement dose range for cognitive performance, formal medical oversight is not strictly required. For users with specific medical conditions, significant medication regimens, or higher doses, medical involvement is appropriate. Users should inform their physicians of L-tyrosine use during routine healthcare encounters to ensure appropriate consideration in clinical decision-making. Research Disclaimer This interaction data is compiled from published research and community reports. It may not be exhaustive. Always consult a healthcare professional before combining compounds. [Sign in for alerts ](/auth) No listings found for L-Tyrosine. Get L-Tyrosine Price Drop Alerts Set a target price and we'll notify you when any vendor drops below it. [Sign in to set alerts](/auth) ### Sign in to leave a review Reviews on BodyHackGuide are tied to verified user accounts and moderated before publishing. Sign in (free, no spam) to share your experience with L-Tyrosine. [Sign in](/auth) ### Related Compounds [View All](/wiki) [ ### 9-Me-BC (9-Methyl-β-carboline) Nootropics Preclinical 9-Methyl--carboline (9-Me-BC) is a synthetic -carboline alkaloid that has drawn nootropic-community interest for a preclinical property that is genuinely unusual among -carbolines: in rodent and cell-culture studies it appears to stimulate the dopaminergic phenotype - raising tyrosine hydroxylase, the number of differentiated dopamine neurons and dopamine content - while also showing neuroprotective, neurorestorative and anti-inflammatory effects, plus in-vitro MAO-A/MAO-B inhibition \[PMID:17913302, PMID:20374418, PMID:32285253\]. t½ Not characterized in humans (no pharmacokinetic data). Community/anecdotal only: ~5-25 mg per day, oral. No validated or approved human dose exists. 6 studies View Profile ](/compound/9-mbc)[ ### Bromantane Nootropics Russia Approved Bromantane is an atypical psychostimulant and anxiolytic developed in the 1980s at the Zakusov Institute of Pharmacology of the Russian Academy of Medical Sciences, originally created as an adaptogen for Soviet military and elite athletic use and later approved in Russia for the treatment of neurasthenic and asthenic disorders under the trade name Ladasten. 34 studies View Profile ](/compound/bromantane)[ ### Dihexa Nootropics Preclinical Dihexa is a synthetic peptide analogue of the angiotensin IV metabolite LVV-hemorphin-7, developed at Washington State University. t½ Not characterized in humans. Dihexa was engineered for metabolic stability (resistant to plasma and enzymatic degradation) and blood-brain-barrier penetration; in preclinical work its central procognitive effects appear to outlast its plasma presence. 5 to 40 mg oral per day (anecdotal range; no established human dose) 1 studies View Profile ](/compound/dihexa)[ ### Kavain Nootropics Preclinical for isolated kavain (in-vitro and animal mechanistic data). Human randomized controlled trials exist for the parent standardized kava extract, of which kavain is the principal kavalactone; the single molecule itself has not been trialed alone. Kavain (kawain) is the principal kavalactone in kava (Piper methysticum) and the main compound behind kava's calming, anxiolytic effect. t½ Not firmly established for isolated kavain in humans. Kavalactones are lipophilic and rapidly absorbed, with subjective effects generally lasting a few hours. Limited pharmacokinetic data preclude a precise elimination half-life. 50000-250000 Preclinical View Profile ](/compound/kavain)[ ### KW-6356 Nootropics Phase 2b (program discontinued) KW-6356 is a selective adenosine A2A receptor antagonist/inverse agonist developed by Kyowa Kirin and studied for Parkinson's disease, both as monotherapy and as an add-on to levodopa. Preclinical View Profile ](/compound/kw-6356)[ ### L-Theanine Nootropics FDA Approved L-Theanine is a non-proteinogenic amino acid found almost exclusively in tea (Camellia sinensis) and a handful of edible mushrooms, and it has become the single most widely-used calm-focus nootropic in the modern supplement market — both on its own at 100-400mg doses and, even more prominently, as the classic 1:1 or 2:1 pair with caffeine that defines the "calm-focus" experiential signature of green tea and of virtually every serious nootropic stack. t½ 1-3 hours (plasma); central CNS effect 3-5 hours 1226 studies View Profile ](/compound/l-theanine) ### Side-by-Side Comparisons [All Comparisons](/compare) [L-Tyrosine vs L-Theanine](/compare/l-theanine-vs-l-tyrosine "L Theanine vs L Tyrosine") [ View Full Dosage Guide → Protocols, calculator & safety for L-Tyrosine ](/guides/dosage/l-tyrosine) ### Related Articles [All Posts](/blog) [ #### Cognitive Enhancers by Mechanism and Safety: A Reference Guide A mechanism-first reference that groups cognitive enhancers into seven pharmacological classes and compares each on how it works and its main safety consideration, with a master table and honest evidence labels. Not a ranking, and not medical advice. 7/1/2026 ](/blog/cognitive-enhancers-by-mechanism-and-safety)[ #### We Compared 8 Focus Nootropics for 90 Days — Here's What Actually Works We tested 8 popular focus nootropics over 90 days using objective metrics — reaction time, deep work hours, and daily focus ratings. Here are the honest results, including costs and side effects. 4/3/2026 ](/blog/best-focus-nootropics-90-day-comparison)[ #### The Biohacker's Complete Nootropic Stack Guide 10 research-backed nootropic stacks for every goal: focus, memory, anxiety, sleep, motivation, creativity, and more. Complete dosing protocols, timing, cycling, and product recommendations. 4/1/2026 ](/blog/complete-nootropic-stack-guide) ### Research Score 16 8 PubMed studies ### Quality Indicators Data Completeness 63% Description Mechanism of Action Chemical Data Dosing Protocols Safety Profile PubMed Studies Interactions Vendor Listings Research Credibility 8 PubMed studies Limited research available ### Quick Facts Trial Phase Preclinical [Full Dosage Guide](/guides/dosage/l-tyrosine)[Calculate Your Dose](/tools/reconstitution) Research Disclaimer This information is for educational and research purposes only. Not intended as medical advice. Consult a healthcare professional before use. ## Frequently Asked Questions What is L-tyrosine and what does it do? L-tyrosine is a non-essential aromatic amino acid and the direct biosynthetic precursor to the catecholamine neurotransmitters dopamine, norepinephrine, and epinephrine. Supplemental tyrosine at 500-2000 mg can support catecholamine synthesis during conditions of elevated demand (acute stress, cold exposure, sleep deprivation, sustained cognitive workload), producing modest cognitive performance protection. It is widely used as a dietary supplement for cognitive performance in demanding conditions. Does L-tyrosine actually work for cognitive enhancement? Yes, but conditionally. The evidence base from military and academic laboratories (Banderet & Lieberman 1989, PMID 2736402; Thomas et al., Neri et al., Deijen et al.) supports modest cognitive performance benefits under stress conditions — cold, altitude, sleep deprivation, sustained cognitive workload. Effect sizes are modest (Cohen's d 0.2-0.5) but real in adequately powered studies. In rested, unstressed users performing routine cognitive tasks, tyrosine produces minimal detectable effects. Use it for specific demanding situations, not as a general daily cognitive booster. What is the best L-tyrosine dose? 500-2000 mg taken 30-60 minutes before anticipated cognitive stress, on an empty stomach or with carbohydrate-only snack. Research doses in military studies were 100-150 mg/kg (roughly 7-12 g for a 70 kg adult), but practical doses of 500-2000 mg produce measurable effects with better tolerability. Beginners start at 500-1000 mg; intermediate users use 1000-2000 mg; advanced users may use 1000-3000 mg per dose with 1-3 doses per day during demanding periods. Is L-tyrosine better on an empty stomach? Yes. Tyrosine competes with other large neutral amino acids (phenylalanine, tryptophan, leucine, isoleucine, valine) for transport into the brain via the LAT1 transporter at the blood-brain barrier. Taking tyrosine with a protein-rich meal reduces brain tyrosine delivery and dampens the cognitive effect. Take tyrosine on an empty stomach or with carbohydrate-only snacks (fruit, juice, bread). Avoid taking with protein shakes, high-protein meals, or meat/dairy/eggs for optimal cognitive effect. Is NALT (N-acetyl-L-tyrosine) better than plain L-tyrosine? No, pharmacokinetic data does not support the bioavailability claims of NALT. While NALT has improved water solubility, it must be deacetylated to L-tyrosine (primarily in kidneys) to enter the catecholamine pathway, and this conversion is incomplete in humans. Studies generally show lower tyrosine delivery from equivalent doses of NALT compared to plain L-tyrosine. Plain L-tyrosine at appropriate doses is the pharmacokinetically preferred form and is usually less expensive. Some users report subjective preference for NALT; these reports do not align with the pharmacokinetic evidence. Can I take L-tyrosine with coffee, modafinil, or other stimulants? Yes, combinations are common and generally well-tolerated. Caffeine + L-tyrosine is a well-tested performance stack from military research. [Modafinil](/compound/modafinil) + L-tyrosine is used to extend modafinil's cognitive effects and reduce fatigue. [Piracetam](/compound/piracetam) + L-tyrosine + choline is a common nootropic stack. [L-Theanine](/compound/l-theanine) + caffeine + L-tyrosine is a popular morning productivity formula. Monitor for cumulative cardiovascular or anxiety effects with high stimulant combinations. AVOID combining L-tyrosine with MAO inhibitors — this combination can produce dangerous catecholamine elevations. What are the main L-tyrosine side effects? Generally minimal. Most common: mild GI effects (nausea, loose stools) usually at higher doses or on empty stomach; mild headache; nervousness or jitteriness in sensitive users; sleep disturbance with late-day dosing. Uncommon: modest BP elevation; thyroid function effects with chronic high-dose use. Serious: MAO inhibitor interaction (dangerous — absolute avoidance); theoretical concern for melanoma progression with high-dose chronic use; hyperthyroidism worsening. At typical supplement doses (500-2000 mg) in healthy users, tyrosine is very well tolerated. Should I take L-tyrosine every day or only when needed? For most users, on-demand use (taking tyrosine specifically before anticipated stress or demanding cognitive work) is preferred over chronic daily supplementation. Chronic daily use produces modest adaptation that may reduce acute effect magnitude. On-demand use preserves the pharmacologic effect. Users with continuous cognitive demands (sustained shift work, ongoing high-stress jobs) may adopt daily supplementation with periodic cycling. The principle: tyrosine works best when used with intention for specific purposes rather than as a generic daily supplement. Will L-tyrosine help with depression or ADHD? Probably not as a primary treatment. L-tyrosine has been studied for depression and ADHD with generally modest and inconsistent results. It is not an established treatment for either condition and does not compare favorably to evidence-based treatments (SSRIs/SNRIs for depression; stimulants or atomoxetine for ADHD). Some users incorporate tyrosine as adjunctive support for dopaminergic or noradrenergic symptoms not addressed by other treatments, but this is self-directed rather than evidence-based. Patients with diagnosed depression or ADHD should work with their prescribing physician rather than self-treating with tyrosine. Is L-tyrosine safe for long-term use? Yes, within typical supplement dose ranges in healthy users. L-tyrosine is a normal dietary amino acid consumed at gram levels daily from food without safety concerns. Supplement doses of 500-2000 mg daily add modestly to dietary intake and are well-tolerated in most users. Long-term chronic high-dose use (>3 g daily for months to years) has not been extensively studied but theoretical concerns exist about thyroid function changes and (weakly) about melanoma risk with very high chronic exposure. Most responsible users adopt on-demand use or moderate daily doses with periodic cycling. Users with specific medical conditions (thyroid disease, melanoma, cardiovascular disease, psychiatric disorders) should discuss long-term use with their physician. ## Research Tools [ ### Peptide Calculator Reconstitution & syringe units ](/tools/reconstitution)[ ### Reconstitution Guide How to mix, step by step ](/guides/how-to-reconstitute-peptides)[ ### Nasal Spray Calc mL per actuation ](/tools/intranasal)[ ### Half-Life Visualizer Decay curves ](/tools/halflife) ## Related Compounds [View All](/wiki) [ ### 9-Me-BC (9-Methyl-β-carboline) Nootropics Preclinical 9-Methyl--carboline (9-Me-BC) is a synthetic -carboline alkaloid that has drawn nootropic-community interest for a preclinical property that is genuinely unusual among -carbolines: in rodent and cell-culture studies it appears to stimulate the dopaminergic phenotype - raising tyrosine hydroxylase, the number of differentiated dopamine neurons and dopamine content - while also showing neuroprotective, neurorestorative and anti-inflammatory effects, plus in-vitro MAO-A/MAO-B inhibition \[PMID:17913302, PMID:20374418, PMID:32285253\]. t½ Not characterized in humans (no pharmacokinetic data). Community/anecdotal only: ~5-25 mg per day, oral. No validated or approved human dose exists. 6 studies View Profile ](/compound/9-mbc)[ ### Bromantane Nootropics Russia Approved Bromantane is an atypical psychostimulant and anxiolytic developed in the 1980s at the Zakusov Institute of Pharmacology of the Russian Academy of Medical Sciences, originally created as an adaptogen for Soviet military and elite athletic use and later approved in Russia for the treatment of neurasthenic and asthenic disorders under the trade name Ladasten. 34 studies View Profile ](/compound/bromantane)[ ### Dihexa Nootropics Preclinical Dihexa is a synthetic peptide analogue of the angiotensin IV metabolite LVV-hemorphin-7, developed at Washington State University. t½ Not characterized in humans. Dihexa was engineered for metabolic stability (resistant to plasma and enzymatic degradation) and blood-brain-barrier penetration; in preclinical work its central procognitive effects appear to outlast its plasma presence. 5 to 40 mg oral per day (anecdotal range; no established human dose) 1 studies View Profile ](/compound/dihexa)[ ### Kavain Nootropics Preclinical for isolated kavain (in-vitro and animal mechanistic data). Human randomized controlled trials exist for the parent standardized kava extract, of which kavain is the principal kavalactone; the single molecule itself has not been trialed alone. Kavain (kawain) is the principal kavalactone in kava (Piper methysticum) and the main compound behind kava's calming, anxiolytic effect. t½ Not firmly established for isolated kavain in humans. Kavalactones are lipophilic and rapidly absorbed, with subjective effects generally lasting a few hours. Limited pharmacokinetic data preclude a precise elimination half-life. 50000-250000 Preclinical View Profile ](/compound/kavain)[ ### KW-6356 Nootropics Phase 2b (program discontinued) KW-6356 is a selective adenosine A2A receptor antagonist/inverse agonist developed by Kyowa Kirin and studied for Parkinson's disease, both as monotherapy and as an add-on to levodopa. Preclinical View Profile ](/compound/kw-6356)[ ### L-Theanine Nootropics FDA Approved L-Theanine is a non-proteinogenic amino acid found almost exclusively in tea (Camellia sinensis) and a handful of edible mushrooms, and it has become the single most widely-used calm-focus nootropic in the modern supplement market — both on its own at 100-400mg doses and, even more prominently, as the classic 1:1 or 2:1 pair with caffeine that defines the "calm-focus" experiential signature of green tea and of virtually every serious nootropic stack. t½ 1-3 hours (plasma); central CNS effect 3-5 hours 1226 studies View Profile ](/compound/l-theanine) ## Side-by-Side Comparisons [All Comparisons](/compare) Compare L-Tyrosine head-to-head: mechanism, half-life, dosing, safety, and live pricing. [L-Tyrosine vs L-Theanine](/compare/l-theanine-vs-l-tyrosine "L Theanine vs L Tyrosine") Free 2026 Peptide Cheat Sheet — 50 pages, PDF Reconstitution math, concentration charts, half-lives, and vendor trust tiers. The reference we wish we had on day one. [Download Free](/guides/peptide-cheat-sheet-download?utm_source=compound-l-tyrosine) ### Need bloodwork before starting? Full hormone + metabolic panels from Anabolic Insights. Code CHONCH for first-order discount. [Order Bloodwork](https://anabolicinsights.ai/?ref=nwm2zjb) ![BodyHackGuide](/assets/bodyhackguide-logo-DOzZNUyh.webp) ### BodyHackGuide Your biohacking research hub — compound pricing, brain health protocols, dosing tools, and vendor reviews. [support@bodyhackguide.co](mailto:support@bodyhackguide.co) [](https://discord.gg/Mhq5UdRYBA)[](https://reddit.com/r/BodyHackGuide)[](https://x.com/bodyhackguide) Explore #### Explore - [Compare prices](/compare) - [Research suppliers](/vendors) - [Deals](/deals) - [Coupons](/coupons) - [Nootropics](/nootropics) - [Brain health](/brain-health) - [Blog](/blog) - [Guides](/guides) Tools #### Tools - [Reconstitution](/tools/reconstitution) - [Dosage calculator](/tools/dosage) - [Half-life visualizer](/tools/halflife) - [COA lookup](/tools/coa) - [Cost calculator](/tools/cost-calculator) - [Stack builder](/stack-builder) - [All tools →](/tools) Trust & vendors #### Trust & vendors - [Vendor directory](/vendors) - [Trust scorecard](/vendors/scorecard) - [Get BHG verified](/vendors/get-vetted) - [Scoring methodology](/vendors/methodology) - [Peptide cheatsheet](/guides/peptide-cheat-sheet-download) Company #### Company - [About](/about) - [Affiliate disclosure](/affiliate-disclosure) - [Editorial standards](/editorial-standards) - [Creators](/creators) - [Coaches](/coaches) - [Privacy](/privacy) - [Terms](/terms) - [Full site directory →](/site-directory) **Ownership & Affiliate Disclosure:** BodyHackGuide and BHG Labs share common ownership. We rank every vendor on the same public, reproducible [methodology](/vendors/methodology), and we earn a commission from purchases made through our links at no extra cost to you. Full details in our [affiliate disclosure](/affiliate-disclosure). **Research Disclaimer:** All compounds listed are for laboratory and research purposes only. Not for human consumption. This site does not sell, distribute, or promote any products. Always consult a qualified healthcare professional and comply with local regulations. © 2026 BodyHackGuide. All rights reserved. · [Terms](/terms) · [Privacy](/privacy) hi 👋